Shockwave Med
Price
Price
Frequently asked questions
What is Shockwave Med's market capitalization?
What is Shockwave Med's Price-to-Earnings (P/E) ratio?
What is the Earnings Per Share (EPS) for Shockwave Med?
What are the analyst ratings and target price for Shockwave Med's stock?
What is Shockwave Med's revenue over the trailing twelve months?
What is the EBITDA for Shockwave Med?
What is the free cash flow of Shockwave Med?
What is the 5-year beta of Shockwave Med's stock?
How many employees does Shockwave Med have, and what sector and industry does it belong to?
Financials
Market Cap
$12.57B5Y beta
1.07EPS (TTM)
$4.267P/E ratio (TTM)
78.45Revenue (TTM)
$787.97MEBITDA (TTM)
$173.45MFree Cashflow (TTM)
$166.14MPricing
Analyst Ratings
The price target is $321.25 and the stock is covered by 10 analysts.
Buy
0
Hold
10
Sell
0
Information
Shockwave Medical, Inc. is a medical device company. The Company is primarily engaged in the development and commercialization of novel technologies that transform the care of patients with cardiovascular disease. The Company is focused on its intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular and heart valve disease. Built on a balloon catheter platform, the IVL technology uses lithotripsy to disrupt both superficial and deep vascular calcium., while minimizing soft tissue injury, and an integrated angioplasty balloon to dilate blockages at low pressures, restoring blood flow. Its Shockwave M5 IVL catheter and Shockwave M5+ IVL catheter are five-emitter catheters for use in its IVL System in medium-diameter vessels for the treatment of peripheral artery disease (PAD). Its Shockwave S4 IVL catheter is a four-emitter catheter for use in its IVL System in small-diameter vessels for the treatment of PAD.
1,468
Medical Equipment & Supplies
Health Care
Identifier
ISIN
Primary Ticker